Georgian Healthcare Group (GHG) has bought a 100% stake in GPC pharmaceutical company.
The deal value made up 14 million USD.
GHG will pay 85.7% of the mentioned sum upon the agreement signature, while the remaining 14.3% ratio will be paid off in a year after successful completion of the deal, in April-May 2017.
The due memorandum was signed on Wednesday and the parties are waiting for a due consent from the regulatory body.
GHG plans to expand its strategy through purchase of GPC to become a leading market player in the Georgian Healthcare System that is valued at 3.4 billion GEL.
GHG also plans to considerably increase the GPC profits margin that recorded only 4% in 2015.